Publications by authors named "David Weinstock"

Claim this Profile
I
Integrating single-cell biophysical and transcriptomic features to resolve functional heterogeneity in mantle cell lymphoma.
Ye Zhang, Lydie Debaize, Adam Langenbucher, Jenalyn Weekes, Ioulia Vogiatzi, David M Weinstock

Sci Adv· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combining MCL-1 inhibition and CD37-directed chimeric antigen receptor T cells as an effective strategy to target T-cell lymphoma.
Tayla B Heavican-Foral, Felix Korell, Irene Scarfò, Caroline R M Wiggers, Allen Thayakumar B, David M Weinstock

Leukemia· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrative Genomic and Transcriptomic Analysis Reveals Targetable Vulnerabilities in Angioimmunoblastic T-Cell Lymphoma.
Alyssa Bouska, Weiwei Zhang, Sunandini Sharma, Harald Holte, Rauf A Shah, David Weinstock

Am J Hematol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrating Single-Cell Biophysical and Transcriptomic Features to Resolve Functional Heterogeneity in Mantle Cell Lymphoma.
Ye Zhang, Lydie Debaize, Adam Langenbucher, Jenalyn Weekes, Ioulia Vogiatzi, David M Weinstock

bioRxiv· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A patient-derived T cell lymphoma biorepository uncovers pathogenetic mechanisms and host-related therapeutic vulnerabilities.
Danilo Fiore, Luca Vincenzo Cappelli, Liu Zhaoqi, Nikita Kotlov, Maria Sorokina, David M Weinstock

Cell Rep Med· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Asciminib plus dasatinib and prednisone for Philadelphia chromosome-positive acute leukemia.
Marlise R Luskin, Mark A Murakami, Julia Keating, Yael Flamand, Eric S Winer, David M Weinstock

Blood· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Duvelisib plus romidepsin in relapsed/refractory T cell lymphomas: a phase 1b/2a trial.
Steven M Horwitz, Ajit J Nirmal, Jahan Rahman, Ran Xu, Esther Drill, David M Weinstock

Nat Med· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
(
(Re)Minding the obvious.
David Weinstock

Hematol Oncol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Duvelisib plus romidepsin in relapsed/refractory T cell lymphomas: a phase 1b/2a trial.
Steven M Horwitz, Ajit J Nirmal, Jahan Rahman, Ran Xu, Esther Drill, David M Weinstock

Nat Med· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Geographic EBV variants confound disease-specific variant interpretation and predict variable immune therapy responses.
Edward L Briercheck, Shashidhar Ravishankar, Elshafa Hassan Ahmed, César Camilo Carías Alvarado, Juan Carlos Barrios Menéndez, David M Weinstock

Blood Adv· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
KLRG1 Cell Depletion as a Novel Therapeutic Strategy in Patients with Mature T-Cell Lymphoma Subtypes.
Bimarzhan Assatova, Robert Willim, Christopher Trevisani, Garrett Haskett, Khyati Maulik Kariya, David M Weinstock

Clin Cancer Res· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutation and cell state compatibility is required and targetable in Ph+ acute lymphoblastic leukemia minimal residual disease.
Peter S Winter, Michelle L Ramseier, Andrew W Navia, Sachit Saksena, Haley Strouf, David M Weinstock

bioRxiv· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acquired Multidrug Resistance in AML Is Caused by Low Apoptotic Priming in Relapsed Myeloblasts.
Elyse A Olesinski, Karanpreet Singh Bhatia, Chuqi Wang, Marissa S Pioso, Xiao Xian Lin, David M Weinstock

Blood Cancer Discov· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Chimeric Antigen Receptor T Cells Targeting CD79b Show Efficacy in Lymphoma with or without Cotargeting CD19.
Maria Ormhøj, Irene Scarfò, Maria L Cabral, Stefanie R Bailey, Selena J Lorrey, David M Weinstock

Clin Cancer Res· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting TRIP13 in favorable histology Wilms tumor with nuclear export inhibitors synergizes with doxorubicin.
Karuna Mittal, Garrett W Cooper, Benjamin P Lee, Yongdong Su, Katie T Skinner, David M Weinstock

Commun Biol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leukemia circulation kinetics revealed through blood exchange method.
Alex B Miller, Felicia H Rodriguez, Adam Langenbucher, Lin Lin, Christina Bray, David M Weinstock

Commun Biol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting lysine demethylase 5 (KDM5) in mantle cell lymphoma.
Danmei Xu, Findlay Bewicke-Copley, Karina Close, Jessica Okosun, Robert Peter Gale, David M Weinstock

Blood Cancer J· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting Aggressive B-cell Lymphomas through Pharmacological Activation of the Mitochondrial Protease OMA1.
Adrian Schwarzer, Matheus Oliveira, Marc-Jens Kleppa, Scott D Slattery, Andy Anantha, David M Weinstock

Mol Cancer Ther· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PD-1 instructs a tumor-suppressive metabolic program that restricts glycolysis and restrains AP-1 activity in T cell lymphoma.
Tim Wartewig, Jay Daniels, Miriam Schulz, Erik Hameister, Abhinav Joshi, David M Weinstock

Nat Cancer· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetically informed therapy for lymphoma: the discomfiting benefit of lumping splits.
Cynthia K Hahn, Adam C Palmer, David M Weinstock

Cancer Cell· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TP63 fusions drive multicomplex enhancer rewiring, lymphomagenesis, and EZH2 dependence.
Gongwei Wu, Noriaki Yoshida, Jihe Liu, Xiaoyang Zhang, Yuan Xiong, David M Weinstock

Sci Transl Med· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leukemia circulation kinetics revealed through blood exchange method.
Alex B Miller, Adam Langenbucher, Felicia H Rodriguez, Lin Lin, Christina Bray, David M Weinstock

bioRxiv· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrated multi-omics analyses reveal homology-directed repair pathway as a unique dependency in near-haploid leukemia.
Yunpeng Liu-Lupo, James Dongjoo Ham, Swarna K A Jeewajee, Lan Nguyen, Toni Delorey, David M Weinstock

Blood Cancer J· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New scaffolds for type II JAK2 inhibitors overcome the acquired G993A resistance mutation.
Matthew L Arwood, Yao Liu, Shannon K Harkins, David M Weinstock, Lei Yang

Cell Chem Biol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting CCR7-PI3Kγ overcomes resistance to tyrosine kinase inhibitors in ALK-rearranged lymphoma.
Cristina Mastini, Marco Campisi, Enrico Patrucco, Giulia Mura, Antonio Ferreira, David M Weinstock

Sci Transl Med· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis